Results 111 to 120 of about 17,066 (197)

The chaperone GRP94 interacts with the proprotein convertase furin and regulates TGF-beta maturation in human primary M2 macrophages. [PDF]

Cell Death Discov
Baverel V, Wang F, Garrido C, Kohli E.
europepmc   +1 more source

Lipid-Lowering Efficacy and Safety of Oral Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors: A Systematic Review and Meta-Analysis. [PDF]

Adv Ther
Masson W, Lobo M, Giunta G, Barbagelata L, Nogueira JP.   +4 more
europepmc   +1 more source

Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9): The Multifaceted Biology, Diseases, and Pharmaceutical Interventions. [PDF]

MedComm (2020)
Kuang J, Hao L, Zhang M, Yang Z.
europepmc   +1 more source

Structural insights into proprotein convertase activation facilitate the engineering of highly specific furin inhibitors. [PDF]

Nat Commun
Klaushofer R, Bloch K, Eder LS, Marzaro S, Schubert M, Böttcher-Friebertshäuser E, Brandstetter H, Dahms SO.   +7 more
europepmc   +1 more source

Substrate selectivity by proprotein convertases

Developmental Biology, 2007
Nelsen, Sylvia M., Christian, Jan L.
openaire   +1 more source

Genetic Pathogenesis of Abdominal Aortic Aneurysm and the Role of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9). [PDF]

Vasc Specialist Int
Choi JY, Gwon JG.
europepmc   +1 more source

Proprotein Convertase Subtilisin/Kexin Type 9 Induces Platelet-Derived Transforming Growth Factor-<i>β</i> to Promote Myocardial Fibrosis After Myocardial Infarction. [PDF]

Hum Mutat
Wang Q, Huang W, Xia D, Wang F, Nair S.
europepmc   +1 more source

Optimization of 4-Amino-2-Pyridone Inhibitors of Proprotein Convertase Subtilisin/Kexin Type 9: Integrating Structure-Activity and Structure-Metabolism Relationships. [PDF]

ChemMedChem
Giannessi L, Lupo MG, Ugolotti M, Papotti B, Mattina B, Martina MG, Demurtas A, Padula C, Nicoli S, Crescenzio M, Ferri N, Zimetti F, Radi M.   +12 more
europepmc   +1 more source

Dramatic Coronary Artery Aneurysm Regression After Coronary Artery Bypass Grafting and Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Therapy. [PDF]

Interdiscip Cardiovasc Thorac Surg
Yokoyama Y, Higashino H, Fujieda H, Abe M.   +3 more
europepmc   +1 more source

Decreasing Proprotein Convertase 5 Causes Hirschsprung's Disease by Disrupting Neural Crest Cell Migration. [PDF]

Cell Mol Gastroenterol Hepatol
Liu Z, Ma Z, Zuo X, Lan C, Chen Y, Liu Z, Zhong W, Chen J, Xie X, Xu X, Wu Q, Huang L, Zeng J, Zhong W, Xia H, Zhang Y.   +15 more
europepmc   +1 more source